Table 1 Completed clinical trials with curcumin in patients affected by cancer
From: Chemopreventive potential of curcumin in prostate cancer
Subjects | Cancer type | Dose | References |
|---|---|---|---|
10 volunteers | Healthy | 500Â mg/day for 1Â week | Soni and Kuttan [103] |
25 patients | Pre-malignant lesions | 500–12,000 mg/day for 3 months | Cheng et al. [23] |
15 patients | Advanced colorectal cancer | 18Â mg | Plummer et al. [83] |
15 patients | Colorectal cancer | 36–180 mg | Sharma et al. [95] |
15 patients | Advanced colorectal cancer | 450–3,600 mg/day for 4 months | Sharma et al. [94] |
12 patients | Hepatic metastases from colorectal cancer | 450–3,600 mg/day for 1 week | Garcea et al. [45] |
12 patients | Colorectal cancer | 450–3,600 mg/day for 1 week | Garcea et al. [46] |
24 volunteers | Healthy | 500–12,000 mg/day | Lao et al. [63] |
17 patients | Advanced pancreatic cancer | 8,000Â mg/day for 2Â months | Dhillon et al. [34] |